Search - tctmd.com

Displaying 1 - 20 of 36

Sort: Relevancy | Date

Presentation TCT 2024

TCT 368: Coronary Physiology After Drug-Eluting Absorbable Metallic Scaffold

Presenter: Ryan Wallace

October 29, 2024

Presentation TCT 2024

TCT 360: Mechanisms of Lumen Reduction After Implantation of a Drug-Eluting Absorbable Metal Scaffold

Presenter: Kirstine Hansen

October 27, 2024

Presentation TCT 2022

TCT 60: The impact of implantation techniques in Absorb BVS and Xience EES on lesion oriented-outcomes at complete five-year follow-up – an AIDA trial QCA substudy

Presenter: Mick Renkens

September 17, 2022

Presentation TCT Abstracts Posters 2019

Impact of Calcified Plaque Angulation on Clinical Outcomes Following Bioresorbable Vascular Scaffold Implantation: Insights from ABSORB III and ABSORB Japan

Presenter: Shinji Imura

September 29, 2019

Presentation TCT 2019

The Post-Absorb BVS Era: Lessons Learned and Implications for Trial Design and Device Approval

Presenter: Andrew Farb

September 28, 2019

Presentation TCT 2019

The Absorb BVS Epilogue: How Did We Miss the Safety Signals?

Presenter: Renu Virmani

September 28, 2019

Presentation TCT 2019

TCT 48: Bioresorbable Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis (COMPARE-ABSORB trial) : Very late device thrombosis while on extended DAPT

Presenter: Robert-Jan Van Geuns

September 25, 2019

Presentation TCT 2019

TCT 47: Five-Year Clinical Outcomes From Randomized Comparison of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents in Patients With Coronary Artery Disease From ABSORB China Trial

Presenter: Run-Lin Gao

September 25, 2019

Presentation

Myocardial Blood Flow and Coronary Flow Reserve 3 Years After Absorb BVS vs DES: VANISH

April 30, 2019

Presentation ESC 2018

ISAR-Absorb MI: A Prospective, Randomized Trial of BVS vs EES in Patients Undergoing Coronary Stenting for Myocardial Infarction

Presenter: Robert Byrne

August 29, 2018

Presentation TCT 2017

Registry Update: BVS STEMI STRATEGY

Presenter: Stephen G. Ellis, Takeshi Kimura, Alfonso Ielasi

October 31, 2017

Presentation

Mid- and Long-term Outcome Comparisons of Absorb BVS vs Everolimus-Eluting Stent

October 17, 2017

Presentation

Economic Outcomes of Absorb BVSvs Everolimus-Eluting Stents in PCI

April 18, 2017

Presentation TCT 2016

Highlights (and My Interpretations) From: Absorb BVS - ABSORB II and ABSORB China (2-3 Year Results)

Presenter: Philip M. Urban, Stephen G. Worthley, Stephen G. Ellis

November 01, 2016

Presentation TCT 2016

The Great Absorb Debate: Is Absorb Ready To Be Used In Most Patients And Lesions? No Short-Term Data Is Borderline, Procedures Are More Costly And Complex, And Long-Term Data Is Scant Best To Wait!

Presenter: Stephen G. Ellis, Corrado Tamburino, Daniel I. Simon

October 31, 2016

Presentation TCT 2016

The Great Absorb Debate: Is Absorb Ready To Be Used In Most Patients And Lesions? Yes With Proper Technique And Planning, Nearly All PCI Patients Can Benefit From BVS!

Presenter: Stephen G. Ellis, Corrado Tamburino, Massimo Napodano

October 31, 2016

Presentation TCT 2016

Outcome Registries VII: IT-DISAPPEARS

Presenter: Stephen G. Ellis, Corrado Tamburino, Anna Sonia Petronio

October 31, 2016

Presentation TCT 2016

Outcome Registries VI: France ABSORB

Presenter: Stephen G. Ellis, Corrado Tamburino, Didier Carrié

October 31, 2016

Presentation TCT 2016

Outcome Registries V: New Insights From GHOST

Presenter: Stephen G. Ellis, Corrado Tamburino

October 31, 2016

Presentation TCT 2016

Outcome Registries IV: The UK Absorb Registry

Presenter: Stephen G. Ellis, Corrado Tamburino, Andreas Baumbach

October 31, 2016

Advertisement

TCT 368: Coronary Physiology After Drug-Eluting Absorbable Metallic Scaffold

TCT 360: Mechanisms of Lumen Reduction After Implantation of a Drug-Eluting Absorbable Metal Scaffold

TCT 60: The impact of implantation techniques in Absorb BVS and Xience EES on lesion oriented-outcomes at complete five-year follow-up – an AIDA trial QCA substudy

Impact of Calcified Plaque Angulation on Clinical Outcomes Following Bioresorbable Vascular Scaffold Implantation: Insights from ABSORB III and ABSORB Japan

The Post-Absorb BVS Era: Lessons Learned and Implications for Trial Design and Device Approval

The Absorb BVS Epilogue: How Did We Miss the Safety Signals?

TCT 48: Bioresorbable Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis (COMPARE-ABSORB trial) : Very late device thrombosis while on extended DAPT

TCT 47: Five-Year Clinical Outcomes From Randomized Comparison of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents in Patients With Coronary Artery Disease From ABSORB China Trial

Myocardial Blood Flow and Coronary Flow Reserve 3 Years After Absorb BVS vs DES: VANISH

ISAR-Absorb MI: A Prospective, Randomized Trial of BVS vs EES in Patients Undergoing Coronary Stenting for Myocardial Infarction

Registry Update: BVS STEMI STRATEGY

Mid- and Long-term Outcome Comparisons of Absorb BVS vs Everolimus-Eluting Stent

Economic Outcomes of Absorb BVSvs Everolimus-Eluting Stents in PCI

Highlights (and My Interpretations) From: Absorb BVS - ABSORB II and ABSORB China (2-3 Year Results)

The Great Absorb Debate: Is Absorb Ready To Be Used In Most Patients And Lesions? No Short-Term Data Is Borderline, Procedures Are More Costly And Complex, And Long-Term Data Is Scant Best To Wait!

The Great Absorb Debate: Is Absorb Ready To Be Used In Most Patients And Lesions? Yes With Proper Technique And Planning, Nearly All PCI Patients Can Benefit From BVS!

Outcome Registries VII: IT-DISAPPEARS

Outcome Registries VI: France ABSORB

Outcome Registries V: New Insights From GHOST

Outcome Registries IV: The UK Absorb Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content